Kristi Kuper, PharmD, BCPS Clinical Director, Infectious Diseases kristine.kuper@cardinalhealth.com
My goal today is to provide you with practical, real-world ideas to help you begin or improve your antimicrobial stewardship program (ASP) Disclosures Employee of Cardinal Health Disclaimer This presentation represents my views, opinions, etc. and not that of my employer
Organization Identifies Goal Administrative/Prescriber Support DATA Resource Inventory/ Program Design Identify Program Goals Implement Program/ Measure/Report/Re-Assess
Someone or a group of someones has identified that the hospital needs to implement an ASP Common motivators JCAHO is asking about it State mandate (California) Clostridium difficile outbreak Reports of poor outcomes among patients with multi-drug resistant Gram negative infections Cost savings
Percent of Total Spend Percent Influenceable
Administration If the C-suite knows what the terms stewardship, or antibiotic resistance means and, even better, uses it in their daily language, you are off to a great start Chief Medical Officer Chief Nursing Officer Chief Operating Officer
Medical Staff Support Identify a physician champion or physician/prescriber groups that will agree to have peer to peer discussions with outlying practitioners Ideally, it is nice if this includes an ID physician but. What if your ID physician(s) is/are not engaged? What if your ID physician(s) is/are opposed to a program?
What if your ID physician is a Rubik s cube? Maybe buy t- shirts?
Which of the following provide an accurate description or the Infectious Disease physician resources available at your hospital? We do not have ID physicians at our hospital. 42% Our ID physicians are in private practice and round on a consultative basis only. Some or all of our ID physicians are employed full time by the hospital. 47% 11% Data on file: Cardinal Health
Hospitalists and Emergency Room physicians Nurse Practitioners and Physician Assistants LTACs Someone should broach the idea of compensation $ per hour Annual stipend Monthly fee Contractual obligation vs just being nice?
Resources Think about what you have vs. need Personnel The most successful programs are inter-disciplinary Look for program extenders Nursing, Case Management, technicians Maximize technology if you can Tools Intervention tracking Other systems within the hospital For example, look at Infection Control tools available Build your own!!
ID physician, ID pharmacist rounds Mondays, Tuesdays, and Thursdays (most weeks) ID physician and pharmacist available via pager M-F during normal business hours to address stewardship issues Clinical and staff pharmacists available after hours and Friday-Sunday to address immediate patient care needs Initial focus: patients on more than 2 antimicrobials, culture and sensitivity results review (focus on de-escalation, discontinuation, and drug-bug mismatches), discharge culture reviews, identification of issues and report back to committee.
Day one- 4 months Intensive Care Units Phase in additional units; 4-8 months ICU step-downs, Oncology, Hemodialysis Phase in additional units; 8-12 months General Medicine and Surgical Floors (1 st phase) Phase in additional units; 12-16 months General Medicine and Surgical Floors (2 nd phase) Phase in additional units; 16-20 months Rehab Any remaining areas; 20-24 months hospital wide within 24 months
Start with the basics Low hanging fruit Set manageable expectations If you already have a program, set your new goals one level up How will you know (objectively) if your program is successful? Wrong answer I gotta a feeling
Examples Reduction in overall antibiotic utilization by 20% Antibiotic start and stop dates will be visible at the point of care In 50% of patient charts by xx/xx/11 In 80% of patient charts by xx/xx/12 Based on a review of 100 general medical and surgical patients who received > 3 antibiotics, only 30% of patients had therapy de-escalated after culture and susceptibility reports were returned. Our goal is to improve this number to 60% by year end
Examples Reduction in overall antibiotic utilization by 20% Antibiotic start and stop dates will be visible at the point of care In 50% of patient charts by xx/xx/11 In 80% of patient charts by xx/xx/12 Based on a review of 100 general medical and surgical patients who received > 3 antibiotics, only 30% of patients had therapy de-escalated after culture and susceptibility reports were returned. Our goal is to improve this number to 60% by year end
18 Identify Program Goals Pick stuff you can fix Please don t make the blanket statement that you are going to decrease ALL antibiotic resistance http://www.idsociety.org/content.aspx?id=11840 Emerg Inf Dis 2007;13(6):838-46
DATA!!!!!!!
Pharmacy Wholesaler purchase reports Antibiotic cost per patient day or per discharge Utilization data from hospital computer system/ finance Defined daily dose per 1000 patient days Order entry data (days of therapy) Medication use AND disease state evaluations Medication safety and adverse drug reactions Infection prevention data Commercial systems Home grown
Lab/Microbiology Blood culture contamination rates MIC trending reports from automated testing system Linezolid, vancomycin, and daptomycin vs MRSA Carbapenem vs Pseudomonas aeruginosa Line listings for key resistant organisms ESBLs MRSA CRE Fall 2008 Me: I think you have KPCs Microbiologist: No we haven t seen it Spring 2009 Pharmacist We have a patient with a KPC Antibiograms
Community hospital in Northeast High level of antibiotic resistance Original First isolate Resistance pattern n= % R n= % R Oxacillin resistant S. aureus 607 66% 317 58% Levofloxacin resistant K. pneumoniae 651 75% 219 58% Tobramycin resistant P. aeruginosa 510 22% 186 22% Make sure resistance changes are real Know where the data is coming from Be aware of impact of breakpoint changes Fortunately, there is a lag time with implementation
Kristi s cliché s of stewardship implementation Rome wasn t built in a day Walk before you run That s a different problem for another day Complete training and education Most hospitals are more successful in implementing the stewardship program in stages vs. all at once Market your program
Pick measurable but manageable outcomes Set frequency to report and re-assess Don t be afraid to make changes
Number of interventions
Poor diagnostic practices High blood culture contamination rates Poor compliance with handwashing Increased hospital acquired infections Poor compliance with hospital infection control practices Relying on one person to be the stewardship program Antagonists
30
31 Society of Infectious Diseases Pharmacists www.sidp.org Johns Hopkins Antibiotic Guide http://www.hopkinsguides.com/hopkins/ub Nebraska Medical Center ASP Homepage http://www.nebraskamed.com/careers/education/asp/ University of Kentucky Chandler Medical Center http://www.hosp.uky.edu/pharmacy/amt/default.html WHO DDD http://www.whocc.no/atc_ddd_index/ CDC Get Smart http://cdc.gov/getsmart/healthcare/improve-efforts/index.html SHEA http://www.sheaonline.org/guidelinesresources/featuredtopicsinhaiprevention/a ntimicrobialstewardship.aspx
Clin Infectious Diseases 2011;53(Supplement 1) Antimicrobial Stewardship Programs: Interventions and Associated Outcomes. Expert Rev Anti Infect Ther. 2008;6(2):209-222. Antimicrobial Resistance Problem Pathogens and Clinical Countermeasures (Owens RC, Lautenbach E, editors) Antibiotics Simplified. (Gallagher JC, MacDougall C, editors) 32
Name (Sponsor) Data Source Website Comments T.E.S.T Tigecycline Evaluation and Surveillance Trial (Pfizer, Formerly Wyeth) Isolates are collected from 130 global centers. Micro testing performed on site and then info entered into a proprietary database http://testsurveillance.com/in dex.php?view=welcome&te mplate=main Susceptibility data limited to drugs that have similar spectrum of activity to tigecycline. Access is free but must register. Susceptibility of Gram Positive Pathogens (Cubist) JMI Labs Central Data Repository http://www.gppathogens.com/data/default. cfm Data is independently maintained by JMI Labs, one of the leaders in antibiotic susceptibility testing. Site only has gram positive info. MYSTIC Meropenem Yearly Susceptibility Test Information Collection (Astra Zeneca) JMI Labs Central Data Repository Not available Data can only be found in published articles. Not searchable. TRUST - Tracking Resistance in the US Today Focus Technologies Central Data Repository Not available Website only contains info on S. pneumoniae resistance patterns but TRUST surveillance tracks Gram negative also. May be able to access more info through Ortho McNeil. 33
Name (Sponsor) Website Comments ABC - Active Bacterial Core Surveillance CDC CDC Antimicrobial Resistance homepage (CDC) http://www.cdc.gov/abcs/reportsfindings/surv-reports.html http://www.cdc.gov/drugresistance/inde x.html Contains annual susceptibility reports for Group A and B Strep, MRSA, N. meningitidis, and S. pneumoniae, and H. influenzae (through 2009). Cannot query. Real time data not available. JMI Laboratories http://jmilabs.com/default.cfm One of the leaders in antimicrobial testing. Posters and abstracts that they have presented are on this website under the Scientific presentations website but are difficult to search for a particular resistance pattern. National Healthcare Safety Network http://www.cdc.gov/nhsn/ Cannot query. Real time data not available. 34
An antimicrobial stewardship can be implemented in any facility regardless of resources May just need to start small Must be interdisciplinary If you work through these steps, you will be right on target
Jae Wu Carpenter, PharmD Arlette Roques MSN, RN, PHN Leigh Ann Keeton, PharmD Karen Michaels, PharmD Mehran Mahdavi, Pharm D, BCOP Brenda Egan, PharmD, BCPS Melissa Steenhoek, PharmD, BCPS Susan Yun, PharmD, BCPS